United States Methotrexate Market Report & Forecast 2021-2027

Publisher Name :
Date: 21-Sep-2021
No. of pages: 93
Inquire Before Buying

United States Methotrexate Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Kg)

United States Methotrexate Market Segment Percentages, By Type, 2020 (%)

- Methotrexate for Injection

- Methotrexate Tablets

United States Methotrexate Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Kg)

United States Methotrexate Market Segment Percentages, By Application, 2020 (%)

- Used for Cancers

- Used for Rheumatoid Arthritis

- Used for Other Diseases

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Methotrexate revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Methotrexate revenues share in United States market, 2020 (%)

Key companies Methotrexate sales in United States market, 2016-2021 (Estimated), (Kg)

Key companies Methotrexate sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Teva Pharmaceutical Industries

- Qualitestrx(DAVA Pharmaceuticals)

- Pfizer (Hospira)

- Roxane Laboratories

- Sine

- Maoxiang

- LingNan Pharmaceutical

- Powerdone

- Huiyu

United States Methotrexate Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Methotrexate Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Methotrexate Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Methotrexate Overall Market Size
2.1 United States Methotrexate Market Size: 2021 VS 2027
2.2 United States Methotrexate Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Methotrexate Sales: 2016-2027
3 Company Landscape
3.1 Top Methotrexate Players in United States Market
3.2 Top United States Methotrexate Companies Ranked by Revenue
3.3 United States Methotrexate Revenue by Companies
3.4 United States Methotrexate Sales by Companies
3.5 United States Methotrexate Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Methotrexate Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Methotrexate Product Type
3.8 Tier 1, Tier 2 and Tier 3 Methotrexate Players in United States Market
3.8.1 List of Tier 1 Methotrexate Companies in United States
3.8.2 List of Tier 2 and Tier 3 Methotrexate Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Methotrexate Market Size Markets, 2021 & 2027
4.1.2 Methotrexate for Injection
4.1.3 Methotrexate Tablets
4.2 By Type - United States Methotrexate Revenue & Forecasts
4.2.1 By Type - United States Methotrexate Revenue, 2016-2021
4.2.2 By Type - United States Methotrexate Revenue, 2022-2027
4.2.3 By Type - United States Methotrexate Revenue Market Share, 2016-2027
4.3 By Type - United States Methotrexate Sales & Forecasts
4.3.1 By Type - United States Methotrexate Sales, 2016-2021
4.3.2 By Type - United States Methotrexate Sales, 2022-2027
4.3.3 By Type - United States Methotrexate Sales Market Share, 2016-2027
4.4 By Type - United States Methotrexate Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Methotrexate Market Size, 2021 & 2027
5.1.2 Used for Cancers
5.1.3 Used for Rheumatoid Arthritis
5.1.4 Used for Other Diseases
5.2 By Application - United States Methotrexate Revenue & Forecasts
5.2.1 By Application - United States Methotrexate Revenue, 2016-2021
5.2.2 By Application - United States Methotrexate Revenue, 2022-2027
5.2.3 By Application - United States Methotrexate Revenue Market Share, 2016-2027
5.3 By Application - United States Methotrexate Sales & Forecasts
5.3.1 By Application - United States Methotrexate Sales, 2016-2021
5.3.2 By Application - United States Methotrexate Sales, 2022-2027
5.3.3 By Application - United States Methotrexate Sales Market Share, 2016-2027
5.4 By Application - United States Methotrexate Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Teva Pharmaceutical Industries
6.1.1 Teva Pharmaceutical Industries Corporation Information
6.1.2 Teva Pharmaceutical Industries Overview
6.1.3 Teva Pharmaceutical Industries Methotrexate Sales and Revenue in United States Market (2016-2021)
6.1.4 Teva Pharmaceutical Industries Methotrexate Product Description
6.1.5 Teva Pharmaceutical Industries Recent Developments
6.2 Qualitestrx(DAVA Pharmaceuticals)
6.2.1 Qualitestrx(DAVA Pharmaceuticals) Corporation Information
6.2.2 Qualitestrx(DAVA Pharmaceuticals) Overview
6.2.3 Qualitestrx(DAVA Pharmaceuticals) Methotrexate Sales and Revenue in United States Market (2016-2021)
6.2.4 Qualitestrx(DAVA Pharmaceuticals) Methotrexate Product Description
6.2.5 Qualitestrx(DAVA Pharmaceuticals) Recent Developments
6.3 Pfizer (Hospira)
6.3.1 Pfizer (Hospira) Corporation Information
6.3.2 Pfizer (Hospira) Overview
6.3.3 Pfizer (Hospira) Methotrexate Sales and Revenue in United States Market (2016-2021)
6.3.4 Pfizer (Hospira) Methotrexate Product Description
6.3.5 Pfizer (Hospira) Recent Developments
6.4 Roxane Laboratories
6.4.1 Roxane Laboratories Corporation Information
6.4.2 Roxane Laboratories Overview
6.4.3 Roxane Laboratories Methotrexate Sales and Revenue in United States Market (2016-2021)
6.4.4 Roxane Laboratories Methotrexate Product Description
6.4.5 Roxane Laboratories Recent Developments
6.5 Sine
6.5.1 Sine Corporation Information
6.5.2 Sine Overview
6.5.3 Sine Methotrexate Sales and Revenue in United States Market (2016-2021)
6.5.4 Sine Methotrexate Product Description
6.5.5 Sine Recent Developments
6.6 Maoxiang
6.6.1 Maoxiang Corporation Information
6.6.2 Maoxiang Overview
6.6.3 Maoxiang Methotrexate Sales and Revenue in United States Market (2016-2021)
6.6.4 Maoxiang Methotrexate Product Description
6.6.5 Maoxiang Recent Developments
6.7 LingNan Pharmaceutical
6.7.1 LingNan Pharmaceutical Corporation Information
6.7.2 LingNan Pharmaceutical Overview
6.7.3 LingNan Pharmaceutical Methotrexate Sales and Revenue in United States Market (2016-2021)
6.7.4 LingNan Pharmaceutical Methotrexate Product Description
6.7.5 LingNan Pharmaceutical Recent Developments
6.8 Powerdone
6.8.1 Powerdone Corporation Information
6.8.2 Powerdone Overview
6.8.3 Powerdone Methotrexate Sales and Revenue in United States Market (2016-2021)
6.8.4 Powerdone Methotrexate Product Description
6.8.5 Powerdone Recent Developments
6.9 Huiyu
6.9.1 Huiyu Corporation Information
6.9.2 Huiyu Overview
6.9.3 Huiyu Methotrexate Sales and Revenue in United States Market (2016-2021)
6.9.4 Huiyu Methotrexate Product Description
6.9.5 Huiyu Recent Developments
7 United States Methotrexate Production Capacity, Analysis
7.1 United States Methotrexate Production Capacity, 2016-2027
7.2 Methotrexate Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Methotrexate Supply Chain Analysis
9.1 Methotrexate Industry Value Chain
9.2 Methotrexate Upstream Market
9.3 Methotrexate Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Methotrexate Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Methotrexate in United States Market
Table 2. Top Methotrexate Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Methotrexate Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Methotrexate Revenue Share by Companies, 2016-2021
Table 5. United States Methotrexate Sales by Companies, (Kg), 2016-2021
Table 6. United States Methotrexate Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Methotrexate Price (2016-2021) & (USD/Kg)
Table 8. Manufacturers Methotrexate Product Type
Table 9. List of Tier 1 Methotrexate Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Methotrexate Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Methotrexate for Injection
Table 12. Major Manufacturers of Methotrexate Tablets
Table 13. By Type - United States Methotrexate Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Methotrexate Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Methotrexate Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Methotrexate Sales (Kg), 2016-2021
Table 17. By Type - United States Methotrexate Sales (Kg), 2022-2027
Table 18. By Application - United States Methotrexate Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Methotrexate Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Methotrexate Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Methotrexate Sales (Kg), 2016-2021
Table 22. By Application - United States Methotrexate Sales (Kg), 2022-2027
Table 23. Teva Pharmaceutical Industries Corporation Information
Table 24. Teva Pharmaceutical Industries Description and Major Businesses
Table 25. Teva Pharmaceutical Industries Methotrexate Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 26. Teva Pharmaceutical Industries Methotrexate Product
Table 27. Teva Pharmaceutical Industries Recent Developments
Table 28. Qualitestrx(DAVA Pharmaceuticals) Corporation Information
Table 29. Qualitestrx(DAVA Pharmaceuticals) Description and Major Businesses
Table 30. Qualitestrx(DAVA Pharmaceuticals) Methotrexate Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 31. Qualitestrx(DAVA Pharmaceuticals) Methotrexate Product
Table 32. Qualitestrx(DAVA Pharmaceuticals) Recent Developments
Table 33. Pfizer (Hospira) Corporation Information
Table 34. Pfizer (Hospira) Description and Major Businesses
Table 35. Pfizer (Hospira) Methotrexate Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 36. Pfizer (Hospira) Methotrexate Product
Table 37. Pfizer (Hospira) Recent Developments
Table 38. Roxane Laboratories Corporation Information
Table 39. Roxane Laboratories Description and Major Businesses
Table 40. Roxane Laboratories Methotrexate Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 41. Roxane Laboratories Methotrexate Product
Table 42. Roxane Laboratories Recent Developments
Table 43. Sine Corporation Information
Table 44. Sine Description and Major Businesses
Table 45. Sine Methotrexate Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 46. Sine Methotrexate Product
Table 47. Sine Recent Developments
Table 48. Maoxiang Corporation Information
Table 49. Maoxiang Description and Major Businesses
Table 50. Maoxiang Methotrexate Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 51. Maoxiang Methotrexate Product
Table 52. Maoxiang Recent Developments
Table 53. LingNan Pharmaceutical Corporation Information
Table 54. LingNan Pharmaceutical Description and Major Businesses
Table 55. LingNan Pharmaceutical Methotrexate Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 56. LingNan Pharmaceutical Methotrexate Product
Table 57. LingNan Pharmaceutical Recent Developments
Table 58. Powerdone Corporation Information
Table 59. Powerdone Description and Major Businesses
Table 60. Powerdone Methotrexate Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 61. Powerdone Methotrexate Product
Table 62. Powerdone Recent Developments
Table 63. Huiyu Corporation Information
Table 64. Huiyu Description and Major Businesses
Table 65. Huiyu Methotrexate Sales (Kg), Revenue (US$, Mn) and Gross Margin (USD/Kg) (2016-2021)
Table 66. Huiyu Methotrexate Product
Table 67. Huiyu Recent Developments
Table 68. Methotrexate Production Capacity (Kg) of Key Manufacturers in United States Market, 2019-2021 (Kg)
Table 69. United States Methotrexate Capacity Market Share of Key Manufacturers, 2019-2021
Table 70. Methotrexate Market Opportunities & Trends in United States Market
Table 71. Methotrexate Market Drivers in United States Market
Table 72. Methotrexate Market Restraints in United States Market
Table 73. Methotrexate Raw Materials
Table 74. Methotrexate Raw Materials Suppliers in United States Market
Table 75. Typical Methotrexate Downstream
Table 76. Methotrexate Downstream Clients in United States Market
Table 77. Methotrexate Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Methotrexate Product Picture
Figure 2. Methotrexate Segment by Type
Figure 3. Methotrexate Segment by Application
Figure 4. United States Methotrexate Market Overview: 2020
Figure 5. United States Methotrexate Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Methotrexate Revenue, 2016-2027 (US$, Mn)
Figure 7. Methotrexate Sales in United States Market: 2016-2027 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Methotrexate Revenue in 2020
Figure 9. Methotrexate for Injection Product Picture
Figure 10. Methotrexate Tablets Product Picture
Figure 11. By Type - United States Methotrexate Sales Market Share, 2016-2027
Figure 12. By Type - United States Methotrexate Revenue Market Share, 2016-2027
Figure 13. By Type - United States Methotrexate Price (USD/Kg), 2016-2027
Figure 14. Used for Cancers
Figure 15. Used for Rheumatoid Arthritis
Figure 16. Used for Other Diseases
Figure 17. By Application - United States Methotrexate Sales Market Share, 2016-2027
Figure 18. By Application - United States Methotrexate Revenue Market Share, 2016-2027
Figure 19. By Application - United States Methotrexate Price (USD/Kg), 2016-2027
Figure 20. Teva Pharmaceutical Industries Methotrexate Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Qualitestrx(DAVA Pharmaceuticals) Methotrexate Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Pfizer (Hospira) Methotrexate Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Roxane Laboratories Methotrexate Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Sine Methotrexate Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Maoxiang Methotrexate Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. LingNan Pharmaceutical Methotrexate Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Powerdone Methotrexate Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Huiyu Methotrexate Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. United States Methotrexate Production Capacity (Kg), 2016-2027
Figure 30. Methotrexate Industry Value Chain
Figure 31. Marketing Channels
  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs